menu

Treating the Individual: Personalized Care Strategies for Patients With Type 2 Diabetes & ASCVD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Treating the Individual: Personalized Care Strategies for Patients With Type 2 Diabetes & ASCVD

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

What types of personalized strategies can we implement to help care for our patients with type 2 diabetes and established cardiovascular disease?

  • Sponsored by

  • Overview

    With atherosclerotic cardiovascular disease (ASCVD) being the number one cause of death and disability for those with type 2 diabetes,1 it’s time we invite our patients to join the fight. Joining Dr. Jennifer Caudle to share how we can implement the latest outcomes-based guidelines and personalized strategies so we can take an individualized approach to caring for patients with type 2 diabetes and ASCVD is interventional cardiologist Dr. Joshua Stolker.

    Reference:
    1. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459-2502. 

    Novo Nordisk is a registered trademark of Novo Nordisk A/S.
    © 2022 Novo Nordisk All rights reserved.
    US22DI00250 August 2022

Schedule7 Dec 2022